About
Vision
VISION
Improve quality of life and contribute to human welfare by developing next-generation biopharmaceuticals
Development of
next-generation
biological drugs
- Platform technology to lead the next-generation of bioconjugate drugs
- Applicable to various protein/peptide drugs
- Applicable to antibodies, chemically synthesized drugs
Biological drugs
for unmet
medical needs
- Focused on existing drugs that are ineffective and with high side effects
- Technology to minimize side effects such as immunogenicity
- Development of orphan drugs with unmet medical demand
Innovative
business
model
- Consulting from the initial stage for global technology transfer
- Collaborate with professional consulting organizations
- Expansion of joint research/global joint clinical trials
